Seattle Allergy & Asthma Research Institute

is a nonprofit clinical research organization focused on answering the biggest questions around allergies and asthma. We conduct studies for companies exploring the new frontiers of medication, medical devices, or treatments for food allergies, environmental allergies, and asthma.

ARE YOU OR YOUR CHILD ELIGIBLE FOR OUR STUDIES?

46

Years of expertise researching allergies and asthma

500

Approximate number of FDA-approved clinical trials to date

10

Number of doctors involved in our research efforts

What We Research

Our Studies

Find out more about ongoing clinical trials and what we’ve already accomplished

LEARN MORE

Participate In Our Research

If you are interested in helping to advance science, we need you!

GET INVOLVED
testimonial

“Our experience at Seattle Allergy & Asthma Research Institute has been nothing but positive. When we were approached about having our 5 year old enter a food allergy treatment study, we were a bit nervous. However, our fears were diminished as soon as we met with the amazing staff. Their levels of professionalism and knowledge gave our family the confidence our daughter was in the safest place for such a trial. The staff made not only our daughter but our entire family feel comfortable and at-easer for the duration of the study. We truly can’t say enough good things about experience! Thank you, SAARI staff!
– Caitlyn (Harlow’s Mom)

Whose Life Will You Change?

   Will it be the 15 million Americans suffering from food allergy?

   235 million people worldwide suffering asthma?

   As a 501(c)3 nonprofit organization, your donations allow us to continue researching and providing answers for those who need it most.

DONATE NOW

IN PARTNERSHIP WITH

Northwest Asthma and Allergy
Seattle Childrens
University of Washington
SeaFac

To hear about the latest news at Seattle Allergy & Asthma Research Institute, follow us on:

Contact Us

To apply to participate in clinical research, please go here. For all other inquiries, please use this form.

Comments